NCT00407069View on ClinicalTrials.gov

Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus

CompletedOBSERVATIONAL
Enrollment

286

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Atopic Dermatitis
Trial Locations (1)

80207

National Jewish Health, Denver

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00407069 - Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus | Biotech Hunter | Biotech Hunter